Tags |
|
|
Links |
|
|
E-Articles - My Favorite UFO - A Personal Investigation
Many UFO researchers—including nearly all the well-known ones—have never seen a UFO. Perhaps this fact makes them more impartial than those of us who have seen UFOs. Personally, I don't think y
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
our experiences or lack thereof determine the quality of your research. Some people who've seen UFOs themselves want to label every light in the sky an alien spacecraft. Some people who've neve
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
r seen a UFO brush off every witness who claims to have seen something extraordinary as a liar or fruitcake.
I understand why some people want to see UFOs everywhere. The reasons why researche
I understand why some people want to see UFOs everywhere. The reasons why researche
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
rs ignore sightings baffles me. In my book Backyard Bigfoot, I chose to share my personal experiences with both Bigfoot and UFOs, for the simple reason that I believe personal experience
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
s can tell us more about both phenomena than dry recitation of the mechanics of the Bigfoot in the Patterson film or the crash at Roswell.
As both a witness and an investigator, I have experie
As both a witness and an investigator, I have experie
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
nced these attitudes. In January of 2004, in Texas, I saw a set of six enormous lights hovering 100 feet off the ground, aligned in two diagonal rows with three lights per row. Each light burne
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
d ten times brighter and larger than any football stadium's lights. I had the impression the lights hung from an enormous object, though I can't quantify the reason for that impression. Since t
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
hen, I have wondered whether the two rows of lights signified two objects; or, perhaps, each light represented an individual object.
The lights hovered above and just behind a horse ranch with
The lights hovered above and just behind a horse ranch with
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
a barn and small caretaker's house. Lights burned inside the barn, yet the ranch seemed eerily still, almost lifeless. We drove a little further down the road, pulling into the driveway for a
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
gas well enclosure. We sat there in a daze for a minute or two. At least, it seemed like a minute or two.
The truth would prove disturbing.
I conducted my own investigation during and after t
The truth would prove disturbing.
I conducted my own investigation during and after t
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
he sighting. Originally, my mother and I spotted the lights from my backyard. We got into my car, drove down the winding country roads, and found the lights. While driving, we could see the glo
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
w from the lights from miles away, over the tops of the hills. A week later, we drove back to the area in daylight but found nothing that could have created the lights. We drove around all side
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
s of the pasture where the lights had hovered. Nothing.
The night of the sighting, we returned to my house thinking the trip had taken 20 minutes. Instead, we discovered the voyage had eaten u
The night of the sighting, we returned to my house thinking the trip had taken 20 minutes. Instead, we discovered the voyage had eaten u
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
p 45 minutes—25 minutes longer than it should have. I had driven on those country roads countless times, and knew how long the trip should've taken. We had lost 25 minutes somewhere along the w
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ay.
At the time, I reported the sighting to a UFO organization. No response. Since that time, I've recounted to the story to other researchers and members of UFO groups. No one expresses the s
At the time, I reported the sighting to a UFO organization. No response. Since that time, I've recounted to the story to other researchers and members of UFO groups. No one expresses the s
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
lightest interest. With all the talk about abductions and missing time, you'd expect someone to evince a mild interest. I don't think my mother and I were abducted. We did, however, have missin
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
g time and a close-up sighting.
I've talked to witnesses who reported their sightings to me because they'd received a dismissive response, or no response at all, from other UFO researchers. So
I've talked to witnesses who reported their sightings to me because they'd received a dismissive response, or no response at all, from other UFO researchers. So
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
me of these witnesses have had extraordinary sightings. I have never figured out why researchers will zero in on one particular case, which seems ordinary to me, and ignore myriad others. When
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
they do investigate a case, many researchers perform a haphazard inquiry, as if the case only marginally interests them.
As witness myself, I understand what people go through after seeing som
As witness myself, I understand what people go through after seeing som
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
ething they can't explain. Perhaps if more researchers had sightings, they would concentrate less on moldy old cases like Roswell and spend more time on new investigations.
©2007 Lisa A. Shiel
©2007 Lisa A. Shiel
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-article.org.ua/article/221653/e-article-My-Favorite-UFO--A-Personal-Investigation.html">My Favorite UFO - A Personal Investigation</a>
BB link (for phorums):
[url=http://www.e-article.org.ua/article/221653/e-article-My-Favorite-UFO--A-Personal-Investigation.html]My Favorite UFO - A Personal Investigation[/url]
Related Articles:
Collaborating For Leveraged Income
Enjoy the Fete Called Life with Personal Finance Secured Loan
Is An Injury Or Illness Keeping You From Buying Life Insurance? You Must Read This
Bookmark it:
|